![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 41, 38021-38028, October 11, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Trescowthick Research Laboratories, Peter MacCallum Cancer
Institute, Locked Bag #1, A'Beckett Street, Melbourne, Vic 8006 Australia and the Understanding the regulation of Akt has been of
major interest for elucidating the control of normal cellular
physiology as well as malignant transformation. The paradigm for
activation of Akt involves phosphatidylinositol
3-kinase-dependent membrane localization followed by
activating phosphorylation of Thr-308 and Ser-473. Many of the
activating signals for Akt involve the stimulation of receptor and
non-receptor tyrosine kinases, and the most potent activator known is
the tyrosine phosphatase inhibitor pervanadate, highlighting a possible
role for tyrosine phosphorylation in the regulation of the enzyme. In
this study we show that activation of Akt by pervanadate or serum is
associated with tyrosine phosphorylation of Akt. In addition, in SKOV3
ovarian carcinoma cells that exhibit high basal levels of Akt activity,
Akt was tyrosine-phosphorylated in the basal state, and this
phosphorylation was further enhanced by both pervanadate and
insulin-like growth factor-1. We have used
NH2-terminal sequencing and phosphate release
analysis to directly identify Tyr-474 as the site of tyrosine
phosphorylation. Substitution of Tyr-474 with phenylalanine abolished
tyrosine phosphorylation of Akt and resulted in up to 55% inhibition
of Akt activation, indicating phosphorylation at Tyr-474 is required for full activation of the kinase. Our data identifies a novel regulatory mechanism for this pleiotropic enzyme that may be applicable to the AGC family of protein kinases given the conserved nature of the
COOH-terminal hydrophobic motif containing Tyr-474.
Direct Identification of Tyrosine 474 as a Regulatory
Phosphorylation Site for the Akt Protein Kinase*,
, and
Friedrich Miescher-Institut, P.O. Box
2543, CH-4002 Basel, Switzerland
*
This work was supported by grants from the Anti Cancer
Council of Victoria and Australian Research Council (to R. B. P.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The on-line version of this article (available at
http://www.jbc.org) contains Supplementary Fig. 4.
§
To whom correspondence should be addressed. Tel.: 61-3-9656-1247;
Fax: 61-3-9656-1411; E-mail:
r.pearson@pmci.unimelb.edu.au.
This article has been cited by other articles:
![]() |
P. A Dennis Targeting Akt in Cancer: Promise, Progress, and Potential Pitfalls Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 25 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Adam, N. K. Mukhopadhyay, J. Kim, D. Di Vizio, B. Cinar, K. Boucher, K. R. Solomon, and M. R. Freeman Cholesterol Sensitivity of Endogenous and Myristoylated Akt Cancer Res., July 1, 2007; 67(13): 6238 - 6246. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Burelout, P. H. Naccache, and S. G. Bourgoin Dissociation between the translocation and the activation of Akt in fMLP-stimulated human neutrophils--effect of prostaglandin E2 J. Leukoc. Biol., June 1, 2007; 81(6): 1523 - 1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E.N. Reiter, X. Wu, L. Sandirasegarane, M. Nakamura, K. A. Gilbert, R. S.J. Singh, P. E. Fort, D. A. Antonetti, and T. W. Gardner Diabetes reduces Basal retinal insulin receptor signaling: reversal with systemic and local insulin. Diabetes, April 1, 2006; 55(4): 1148 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Jung, D. W. Kim, Y. S. Jo, H. K. Chung, J. H. Song, J. S. Park, K. C. Park, S. H. Park, J. H. Hwang, K.-W. Jo, et al. Regulation of Protein Kinase B Tyrosine Phosphorylation by Thyroid-Specific Oncogenic RET/PTC Kinases Mol. Endocrinol., November 1, 2005; 19(11): 2748 - 2759. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-L. Cui, W.-H. Zheng, R. Quirion, and G. Almazan Inhibition of Src-like Kinases Reveals Akt-dependent and -independent Pathways in Insulin-like Growth Factor I-mediated Oligodendrocyte Progenitor Survival J. Biol. Chem., March 11, 2005; 280(10): 8918 - 8928. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhang, J. H. Ostrander, E. J. Faivre, A. Olsen, D. Fitzsimmons, and C. A. Lange Regulated Association of Protein Kinase B/Akt with Breast Tumor Kinase J. Biol. Chem., January 21, 2005; 280(3): 1982 - 1991. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Castillo, J. Brognard, P. A. Petukhov, C. Zhang, J. Tsurutani, C. A. Granville, M. Li, M. Jung, K. A. West, J. G. Gills, et al. Preferential Inhibition of Akt and Killing of Akt-Dependent Cancer Cells by Rationally Designed Phosphatidylinositol Ether Lipid Analogues Cancer Res., April 15, 2004; 64(8): 2782 - 2792. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Papapetropoulos, D. Fulton, M. I. Lin, J. Fontana, T. J. McCabe, S. Zoellner, G. Garcia-Cardena, Z. Zhou, J.-P. Gratton, and W. C. Sessa Vanadate Is a Potent Activator of Endothelial Nitric-Oxide Synthase: Evidence for the Role of the Serine/Threonine Kinase Akt and the 90-kDa Heat Shock Protein Mol. Pharmacol., February 1, 2004; 65(2): 407 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Povsic, T. A. Kohout, and R. J. Lefkowitz {beta}-Arrestin1 Mediates Insulin-like Growth Factor 1 (IGF-1) Activation of Phosphatidylinositol 3-Kinase (PI3K) and Anti-apoptosis J. Biol. Chem., December 19, 2003; 278(51): 51334 - 51339. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, H. Al-Hasani, T. Olausson, A.-M. Wenthzel, U. Smith, and S. W. Cushman Activity, phosphorylation state and subcellular distribution of GLUT4-targeted Akt2 in rat adipose cells J. Cell Sci., September 1, 2003; 116(17): 3511 - 3518. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Pengal, L. P. Ganesan, H. Fang, C. B. Marsh, C. L. Anderson, and S. Tridandapani SHIP-2 Inositol Phosphatase Is Inducibly Expressed in Human Monocytes and Serves to Regulate Fc{gamma} Receptor-mediated Signaling J. Biol. Chem., June 13, 2003; 278(25): 22657 - 22663. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |